BPS Nuclear Pharmacy Certification Examination Practice Test
Nuclear pharmacy combines radiopharmaceutical preparation and handling with radiation safety, measurement, and dose control. This practice material samples tasks such as documenting radioactive-material receipt, selecting shielding, checking radiopharmaceutical quality, and verifying patient-specific doses. It also touches on the physical principles behind nuclear imaging, including positron annihilation and detection of emitted photons.
Exam overview
About the BPS Nuclear Pharmacy Certification Examination Exam
The questions connect radiation physics with routine pharmacy decisions. They address how shielding choices depend on emission type and energy, how a lead syringe shield reduces exposure during handling, and how scintillation cocktails support measurement of low-energy emissions. Preparation scenarios consider labeling a technetium-99m kit, observing its incubation period, and assessing formulation characteristics such as tonicity for intravenous use. Quality-control and operational decisions include responding to an out-of-range dose calibrator check-source result, maintaining traceability records, and confirming that a prescribed activity is appropriate to the patient’s documented age and weight. Patient identification immediately before administration is another safety focus. Together, these scenarios exercise careful measurement, documentation, product handling, and escalation when a result or prescription appears inconsistent.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
A nuclear pharmacy receives a shipment of radioactive material. Which recordkeeping detail is most useful for maintaining traceability of the received material?
Show answer
Correct answer: BRecording material identity and receipt information supports inventory control, reconciliation, and traceability from receipt through use or disposal. The other details do not reliably identify or account for the radioactive material.
For a typical diagnostic radiopharmaceutical, what is the primary purpose of using a lead syringe shield during handling?
Show answer
Correct answer: BA lead syringe shield attenuates radiation emitted by the syringe contents and thereby reduces occupational exposure, particularly to the hands. It does not replace aseptic handling or required dose measurement.
Which statement best describes the purpose of shielding a high-energy beta-emitting source with a low-atomic-number material before adding denser shielding?
Show answer
Correct answer: AHigh-energy beta particles interacting with high-atomic-number materials can generate bremsstrahlung X-rays. A low-atomic-number material can reduce this production, with denser shielding added as appropriate to attenuate remaining photons.
A positron emitted by a PET radionuclide travels a short distance in tissue before annihilation. What physical process produces the pair of 511-keV photons commonly detected in PET?
Show answer
Correct answer: AAfter losing kinetic energy, a positron annihilates with an electron. The process usually produces two photons of approximately 511 keV emitted in nearly opposite directions, which form the basis of PET coincidence detection.
Why should an administered radiopharmaceutical dose be matched to the correct patient using reliable identifiers immediately before administration?
Show answer
Correct answer: APatient identification is a core medication-safety step that helps prevent wrong-patient administration. It does not alter the radionuclide’s physical properties or guarantee imaging outcomes.
A nuclear pharmacy uses a liquid scintillation counter for a test requiring measurement of low-energy emissions. What is the general function of the scintillation cocktail?
Show answer
Correct answer: BIn liquid scintillation counting, energy deposited in the cocktail produces light, and the instrument detects the resulting pulses. The cocktail enables measurement of suitable emissions but does not establish chemical purity or alter the radionuclide into a stable isotope.
A technetium-99m radiopharmaceutical is prepared from a commercial kit. Why is the prescribed post-labeling incubation time observed before use?
Show answer
Correct answer: AKit labeling requires time for the radionuclide and kit components to react. The specified time and conditions support the intended labeled product; incubation does not sterilize the preparation or remove unbound activity.
How to use this practice test
Access is free. Each session presents up to 20 random questions from the 50-question practice bank, with results shown after the session. Use the results to identify which concepts need another pass—for example, radiation shielding, dose-calibrator checks, radiopharmaceutical preparation, or patient-specific dose verification.
Preparation tips
- Compare shielding approaches for beta and photon emissions, including why a low-atomic-number layer may be used before denser shielding for high-energy beta sources.
- Review the purpose of dose-calibrator check sources and define the action your workplace procedures require when a result is outside its acceptable range.
- Practice explaining what occurs after positron emission and why annihilation produces two 511-keV photons detected in PET.
- For technetium-99m kit preparation, connect the prescribed incubation interval to labeling and product quality rather than treating it as an arbitrary wait.
- Work through dose-verification scenarios using patient identifiers and relevant patient details, and identify when an apparent activity discrepancy needs clarification before dispensing.